We are delighted to announce the release of a new scientific publication in collaboration with the University of Newcastle on modelling Stargardt disease (STGD1) in vitro with retinal organoids (RO)!
During this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.
Speakers:
Share on social media:
Don't miss out on our latest innovations: follow us on Linkedin